(2E)-3-(2-chlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(S)-TRIP, ?98.0%, 5g

2-Chloro-N-(2,3-dichloro-phenyl)-acetamide, 1g

3-(1H-Imidazol-4-yl)propanoic acid, 95.0%, 250mg

2-Bromo-4'-fluoroacetophenone, 97.0%, 10g

3-Chloro-2-hydroxybenzoic acid, 99.00%, 1g

tert-Butyl ethyl ether, 95.0%, 25ml

GC capillary column ROTI®Cap-1, 50 m, 0.32 mm, 0.35 µm, 1 Piece(s)

1-chloro-3-(2,6-dichlorophenyl)propan-2-one, 95.0%, 10g

Sodium 2-(4-chlorophenoxy)acetate, 95.0%, 1kg

(5-Methyl-1,3,4-oxadiazol-2-yl)methanol, 95.0%, 250mg

5-Methyl-6,7-dihydro-5H-cyclopenta[b]pyrazine, 95.0%, 100g

1,7-BIS(TERT-BUTOXYCARBONYLMETHYL)-1,4,7,10-TETRAAZACYCLODODECANE, 95%, 10g